Articles by Charlotte Ridler

How non-cancerous cells in pancreatic cancer may weaken the immune system’s response

12th December 2024

New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.

Read more

Professor Sarah McClelland awarded £1.5m from CRUK to study cancer’s chromosomal chaos

25th November 2024

Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.

Read more

Cancer-killing virus treatment shows promise in brain tumour trial

8th November 2024

An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.

Read more

€9.8m ERC Synergy grant awarded to study how human tissues stay healthy as we age

5th November 2024

Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.

Read more

BCI paves the way for the next era of radiation research in £18m partnership

30th October 2024

The BCI is advancing radiation research through the Cancer Reserach UK City of London Radiation Research Centre of Excellence, an £18M partnership with the Crick, UCL and King’s.

Read more

International study reveals four distinct types of oesophageal cancer

23rd October 2024

New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.

Read more

Search News
Categories
Archives
Tags